Project Grant HT94252310185
Award Date
8/1/23
Completion Date
7/31/25
Dollars Obligated
$149K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
The University of Alabama at Birmingham (UAB) will receive $148,500 through August 31, 2025 to conduct research targeting Schwann cell-mediated cancer progression and metastasis under a Project Grant from the Defense Health Agency. This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health through innovative medical solutions. The funding will allow UAB...
The University of Alabama at Birmingham (UAB) was awarded a $650,845 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 1, 2025, will support UAB's research into developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. This research aims to transform healthcare for military service members and the broader public by advancing innovative approaches...
The University of Alabama at Birmingham (UAB) was awarded a $1,361,285 Phase 1/2 clinical trial grant by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a trial of the MEK inhibitor mirdametinib and TYK2 inhibitor deucravacitinib for advanced malignant peripheral nerve sheath tumors. This federally funded research project aims to advance innovative medical treatments and technologies to...
The University of Alabama at Birmingham (UAB) was awarded a $907,805 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award beginning April 15, 2022 will support research entitled "Elevated Uracil Glycosylase Coupled to Reduced Base Excision Repair Promotes AA PCA Progression." Per the grant details, UAB will investigate how specific DNA repair mechanisms may promote the progression...
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
The University of Alabama at Birmingham (UAB) received a $1,139,184.00 Project Grant award from the Defense Health Agency for the research project "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA". The award, which began on August 15, 2023 and is scheduled for completion on August 14, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). This grant supports UAB's biomedical research efforts to transform health care for Service...
The University of Alabama at Birmingham will receive $670,729 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on DNA damage as a predictive biomarker for immunotherapy response in ovarian cancer. The three-year project grant awarded in July 2021 will support research to investigate medical solutions for the battlefield by exploring DNA damage as a potential predictor of whether patients...
The University of Alabama at Birmingham (UAB) received a $724,115 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, awarded on September 1, 2024, is to conduct research on the utility of sodium nitrite in improving recovery after spinal cord injuries. As a leading research institution, UAB will leverage its expertise in biomedical engineering, neuroscience, and clinical trials to...
The University of Alabama will receive $749,987 under a three-year Project Grant award from the Defense Health Agency to investigate the role of environmental stressors on veteran neurocognitive aging. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will support research from May 2023 to April 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research. This award will...